N-[2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyethyl]-5-[4-[3-(ethylamino)-3-oxopropyl]triazol-1-yl]pentanamide

C32H55N5O18 — CID 167622764

IUPACN-[2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyethyl]-5-[4-[3-(ethylamino)-3-oxopropyl]triazol-1-yl]pentanamide
SMILESCCNC(=O)CCc1cn(CCCCC(=O)NCCO[C@@H]2O[C@H](CO[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@H]2O)nn1
InChIInChI=1S/C32H55N5O18/c1-2-33-20(41)7-6-15-11-37(36-35-15)9-4-3-5-19(40)34-8-10-50-31-28(49)29(55-32-27(48)25(46)22(43)17(13-39)53-32)23(44)18(54-31)14-51-30-26(47)24(45)21(42)16(12-38)52-30/h11,16-18,21-32,38-39,42-49H,2-10,12-14H2,1H3,(H,33,41)(H,34,40)/t16-,17-,18-,21-,22-,23-,24+,25+,26+,27+,28-,29+,30+,31-,32-/m1/s1
InChIKeyAPRBBNYVNPQFQM-WZSWBUMTSA-N
MW797.81 g/mol
LogP-6.90
Rot. Bonds20

About N-[2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyethyl]-5-[4-[3-(ethylamino)-3-oxopropyl]triazol-1-yl]pentanamide

N-[2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyethyl]-5-[4-[3-(ethylamino)-3-oxopropyl]triazol-1-yl]pentanamide (PubChem CID 167622764) has the molecular formula C32H55N5O18 and a molecular weight of 797.81 g/mol. Its IUPAC name is N-[2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyethyl]-5-[4-[3-(ethylamino)-3-oxopropyl]triazol-1-yl]pentanamide.

Molecular Properties

Compound NameN-[2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyethyl]-5-[4-[3-(ethylamino)-3-oxopropyl]triazol-1-yl]pentanamide
PubChem CID167622764
Molecular FormulaC32H55N5O18
Molecular Weight797.81 g/mol
Exact Mass797.35
IUPAC NameN-[2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyethyl]-5-[4-[3-(ethylamino)-3-oxopropyl]triazol-1-yl]pentanamide
SMILESCCNC(=O)CCc1cn(CCCCC(=O)NCCO[C@@H]2O[C@H](CO[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@H]2O)nn1
InChIInChI=1S/C32H55N5O18/c1-2-33-20(41)7-6-15-11-37(36-35-15)9-4-3-5-19(40)34-8-10-50-31-28(49)29(55-32-27(48)25(46)22(43)17(13-39)53-32)23(44)18(54-31)14-51-30-26(47)24(45)21(42)16(12-38)52-30/h11,16-18,21-32,38-39,42-49H,2-10,12-14H2,1H3,(H,33,41)(H,34,40)/t16-,17-,18-,21-,22-,23-,24+,25+,26+,27+,28-,29+,30+,31-,32-/m1/s1
InChIKeyAPRBBNYVNPQFQM-WZSWBUMTSA-N
XLogP-6.90
TPSA346.59 Ų
H-Bond Donors12
H-Bond Acceptors21
Rotatable Bonds20
Heavy Atoms55
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500797.81
LogP ≤ 5-6.90
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyethyl]-5-[4-[3-(ethylamino)-3-oxopropyl]triazol-1-yl]pentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyethyl]-5-[4-[3-(ethylamino)-3-oxopropyl]triazol-1-yl]pentanamide?
The IUPAC name of N-[2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyethyl]-5-[4-[3-(ethylamino)-3-oxopropyl]triazol-1-yl]pentanamide (CID 167622764) is N-[2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyethyl]-5-[4-[3-(ethylamino)-3-oxopropyl]triazol-1-yl]pentanamide.
What is the SMILES notation for N-[2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyethyl]-5-[4-[3-(ethylamino)-3-oxopropyl]triazol-1-yl]pentanamide?
The canonical SMILES for N-[2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyethyl]-5-[4-[3-(ethylamino)-3-oxopropyl]triazol-1-yl]pentanamide is CCNC(=O)CCc1cn(CCCCC(=O)NCCO[C@@H]2O[C@H](CO[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@H]2O)nn1.
What is the InChIKey of N-[2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyethyl]-5-[4-[3-(ethylamino)-3-oxopropyl]triazol-1-yl]pentanamide?
The InChIKey is APRBBNYVNPQFQM-WZSWBUMTSA-N. The full InChI is InChI=1S/C32H55N5O18/c1-2-33-20(41)7-6-15-11-37(36-35-15)9-4-3-5-19(40)34-8-10-50-31-28(49)29(55-32-27(48)25(46)22(43)17(13-39)53-32)23(44)18(54-31)14-51-30-26(47)24(45)21(42)16(12-38)52-30/h11,16-18,21-32,38-39,42-49H,2-10,12-14H2,1H3,(H,33,41)(H,34,40)/t16-,17-,18-,21-,22-,23-,24+,25+,26+,27+,28-,29+,30+,31-,32-/m1/s1.
What are the key properties of N-[2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyethyl]-5-[4-[3-(ethylamino)-3-oxopropyl]triazol-1-yl]pentanamide?
N-[2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyethyl]-5-[4-[3-(ethylamino)-3-oxopropyl]triazol-1-yl]pentanamide has a molecular weight of 797.81 g/mol, XLogP of -6.90, 20 rotatable bonds, 12 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyethyl]-5-[4-[3-(ethylamino)-3-oxopropyl]triazol-1-yl]pentanamide is sourced from PubChem (CID 167622764), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).